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Abstract
Borrelia burgdorferi, the agent of Lyme disease, is a spirochetal pathogen with limited metabolic capabilities that survives
under highly disparate host-specific conditions. However, the borrelial genome encodes several proteins of the mevalonate
pathway (MP) that utilizes acetyl-CoA as a substrate leading to intermediate metabolites critical for biogenesis of
peptidoglycan and post-translational modifications of proteins. In this study, we analyzed the MP and contributions of
acetate in modulation of adaptive responses in B. burgdorferi. Reverse-transcription PCR revealed that components of the
MP are transcribed as individual open reading frames. Immunoblot analysis using monospecific sera confirmed synthesis of
members of the MP in B. burgdorferi. The rate-limiting step of the MP is mediated by HMG-CoA reductase (HMGR) via
conversion of HMG-CoA to mevalonate. Recombinant borrelial HMGR exhibited a Km value of 132 mM with a Vmax of
1.94 mmol NADPH oxidized minute
21 (mg protein)
21 and was inhibited by statins. Total protein lysates from two different
infectious, clonal isolates of B. burgdorferi grown under conditions that mimicked fed-ticks (pH 6.8/37uC) exhibited
increased levels of HMGR while other members of the MP were elevated under unfed-tick (pH 7.6/23uC) conditions.
Increased extra-cellular acetate gave rise to elevated levels of MP proteins along with RpoS, CsrABb and their respective
regulons responsible for mediating vertebrate host-specific adaptation. Both lactone and acid forms of two different statins
inhibited growth of B. burgdorferi strain B31, while overexpression of HMGR was able to partially overcome that inhibition. In
summary, these studies on MP and contributions of acetate to host-specific adaptation have helped identify potential
metabolic targets that can be manipulated to reduce the incidence of Lyme disease.
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Introduction
Lyme disease is the most prevalent arthropod-borne disease in
the United States with nearly 30,000 cases reported to the Centers
for Disease Control and Prevention (CDC) in 2010 [1]. The
disease is caused by a spirochetal pathogen, Borrelia burgdorferi,
following transmission from infected ticks belonging to the Ixodes
spp [2,3]. The incidence of Lyme disease is highest in geographic
areas where there are increased ecological interactions between
humans, reservoir hosts infected with B. burgdorferi, and transmis-
sion vectors [3–11]. Lyme disease is a multi-phasic disorder
leading to severe arthritis, carditis, and/or neuroborreliosis if
untreated during the early stages of infection [5–10]. While
doxycycline is the antibiotic of choice for treatment during early
stage Lyme disease, the efficacy of antibiotics can be variable in
patients presenting with established, late-stage B. burgdorferi
infection [12,13]. Currently, no vaccines are available against
Lyme disease in humans [14], necessitating development of
alternate strategies to limit the transmission of B. burgdorferi to
humans and thus reducing the incidence of Lyme disease.
B. burgdorferi is unique among bacteria since it is neither Gram-
positive nor Gram-negative, as it does not possess the typical
lipopolysaccharide (LPS) characteristic of Gram-negative bacteria
[15]. The B. burgdorferi genome is rather unique in that several key
metabolic pathways for synthesis of essential compounds such as
amino acids, nucleic acids, and fatty acids are absent [16]. Thus,
the bacterium is intimately associated with its host in order to
acquire these required nutrients. The largest components of the
outer membrane lipid mass of B. burgdorferi are two glycolipids
identified as cholesteryl 6-O-acyl-b-D-galactopyranoside (BbGL-I;
23.2%) and 1,2-di-O-acyl-3-O-a-D-galactopyranosyl-sn-glycerol
(BbGL-II; 12.4%) [17–20]. A third glycolipid, cholesteryl-b-D-
galactopyranoside, also makes up a portion of the outer
membrane. These glycolipids function in a manner similar to
LPS in that they are important outer membrane components,
surface exposed, and able to elicit antibody responses in mice [17–
20]. The outer membrane also has free cholesterol and other
cholesterol esters [20], suggesting that either biogenesis of
acquisition of cholesterol is an important metabolic requirement
for B. burgdorferi.
Sequence analysis of the borrelial genome indicates the presence
of homologs (bb0683-bb0688) of the mevalonate pathway (MP)
leading to the synthesis of isopentenyl-5-pyrophosphate (IPP);
however, there was a conspicuous lack of homologs that will lead
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component of several isoprenoids and a precursor for peptidogly-
can synthesis contributing to the structural integrity of several
organisms [21–26]. The MP is responsible for synthesis of IPP in
archaea, eukaryotes, and some eubacteria where mevalonate is a
key intermediate of the pathway [27,28]. The rate-limiting step of
the MP in eukaryotes is the reduction of 3-hydroxy-3-methyl-
glutaryl-coenzyme A (HMG-CoA) to mevalonate by HMG-CoA
reductase (HMGR; EC 1.1.1.88) [21–23,26,29,30]. In humans,
HMGR is the target of HMGR inhibitors referred to as statins
[31–33]. The inhibition of HMGR by statins is responsible for
lowering levels of plasma low-density lipoproteins (LDL) leading to
a reduction in several clinical manifestations that are directly or
indirectly linked to elevated levels of LDL [30,31,33–35].
Moreover, due to the central role played by IPP in isoprenoid
synthesis, organisms that do not possess MP have an alternate
pathway for the synthesis of IPP [27]. The 2-C-methyl-D-erythritol
4-phosphate/1-deoxy-D-xylulose 5-phosphate (MEP/DOXP)
pathway is found in most eubacteria and some plants where it is
used in tandem with MP or exclusively to synthesize IPP [27,28].
The absence of homologs leading to the synthesis of cholesterol
from IPP suggests that B. burgdorferi most probably acquires
cholesterol derivatives from its hosts and key intermediates of the
MP are utilized for the biogenesis of peptidoglycan or for post-
translational modification of proteins such as incorporation of
prenyl groups. Hence, it appears that the MP could play a critical
role in not only providing the key intermediates required for
synthesis of peptidoglycan and/or the cell wall but also for
borrelial surface determinants that mediate interactions of B.
burgdorferi with its vertebrate or invertebrate hosts. Moreover,
cholesterol and its derivatives could also play a role in the synthesis
of glycolipids and post-transcriptional modifications in concert
with MP contributing to the host-pathogen interactions of B.
burgdorferi.
Recently, we and others have analyzed the role of Carbon
Storage Regulator A of B. burgdorferi (CsrABb) in regulating the
adaptation of B. burgdorferi for infection of the vertebrate host
[6,10,36–38]. Sze and Li showed that CsrABb represses phosphate
acetyltransferase (Pta) leading to increased accumulation of acetyl
phosphate which in turn leads to activation of the Rrp2-RpoN-
RpoS pathway [37,39]. A number of studies have shown that this
pathway drives expression of a variety of determinants that
facilitate transmission of B. burgdorferi from the tick vector and
mediate interaction with vertebrate host-specific proteins
[11,36,40–48]. Moreover, we have also shown that one of the 5
oligopeptide permeases containing a solute binding domain plays a
role in the intracellular accumulation of acetate from the
extracellular milieu affecting vertebrate host-specific adaptation
[9]. Since the MP in B. burgdorferi is dependent on levels of acetyl-
CoA, the extracellular concentrations of acetate, its transport from
the extracellular environment, and conversion to acetyl-CoA via
the enzymes acetate kinase (AckA) and phosphate acetyltransferase
Figure 1. A model for the role of acetate in modulating the vertebrate host-specific adaptation and the mevalonate pathway in B.
burgdorferi. Intracellular levels of acetate contribute to the activation of the Rrp2-RpoN-RpoS pathway leading to the adaptation of B. burgdorferi to
vertebrate host-specific conditions and provide the initiating substrate for the mevalonate pathway. It appears that acetate plays a central role in
modulating host-specific adaptation to central metabolic functions critical for survival of B. burgdorferi under different environmental conditions. The
rate-limiting step of the mevalonate pathway, HMG-CoA reductase (HMGR), is a potential chemotherapeutic target that can be exploited to reduce
the survival of B. burgdorferi and hence a reduction in the incidence of Lyme disease. Sequence analysis of members of the MP in B. burgdorferi
indicated significant similarity with ORFs of the MP that have been characterized in L. monocytogenes, P. mevalonii and S. aureus (Table 4) [16]. Based
on this analysis, B. burgdorferi appears to possess all open reading frames (ORFs bb0683 to bb0688) necessary for the production of IPP via the
mevalonate pathway [16].
doi:10.1371/journal.pone.0038171.g001
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linking the host-specific modulation of B. burgdorferi and key
metabolic pathways for cell wall biogenesis and post-translational
modifications.
In this study, we characterize the MP and the role of levels of
acetate in modulating the MP and vertebrate host-specific
adaptation in B. burgdorferi. Using recombinant borrelial HMGR,
we examined the kinetics of mevalonate formation and the
inhibitory effects of select statins on growth of B. burgdorferi.
Additionally, we determined differential expression of MP
members under conditions mimicking the unfed- and fed-tick
midgut and the concomitant effects of supplemental acetate on
host-specific adaptation and levels of key components of the MP in
B. burgdorferi. These studies will aid in identification and design of
compounds that inhibit this central metabolic pathway that could
potentially affect both the survival of B. burgdorferi but also its ability
to exhibit its pathogenic effects in vertebrate hosts. Analysis of
these potential inhibitory compounds should add to the array of
strategies to reduce the incidence and debilitating effects of Lyme
disease in endemic areas.
Materials and Methods
Bacterial Strains and Growth Conditions
Two clonal, infectious isolates of B. burgdorferi strain B31 (MSK5
and A3) and one non-infectious isolate (ML23) were used in this
study [49,50]. All B. burgdorferi cultures used for transcriptional
analysis were grown in 1% CO2 at 32uC in BSK-II liquid medium
(pH 7.6) supplemented with 6% normal rabbit serum (Pel-Freez
Biologicals, Rogers, AR) [49,51]. We propagated B. burgdorferi
strain B31 (clonal isolates MSK5 and A3 that carry the full
complement of plasmids needed for infection of the vertebrate
host) to a density of 5610
7 spirochetes/ml in BSK-II growth
medium. The tick mid-gut, before (unfed-tick, pH 7.6/23uC) and
after (fed-tick, pH 6.8/37uC) a blood meal [5–10], was mimicked
in order to determine if these environmental signals altered levels
of proteins of the MP. B. burgdorferi strain B31-A3 was grown under
fed-tick (pH 6.8/37uC), laboratory (pH 7.6/32uC), and unfed-tick
(pH 7.6/23uC) specific conditions with varying concentrations of
supplemental sodium acetate (0, 15, 30, and 90 mM) [9,38]. The
spirochetes were grown to a density of 5610
7 cells/ml and washed
in Hanks Balanced Salt Solution (HBSS, Thermo Scientific
HyClone, Logan, UT) three times to remove BSK-II growth
medium and processed further for analysis of proteins. Escherichia
coli TOP10 (Invitrogen, Carlsbad, CA), M15 (QIAgen, Valencia,
CA), and Rosettagami (Novagen) strains were used for all
procedures involving cloning and overexpression of recombinant
proteins, respectively. The E. coli strains were cultured in Luria-
Bertani (LB) broth supplemented with appropriate concentrations
of antibiotics [5].
Transcriptional Analysis of ORFs of the MP
In order to determine if the ORFs of the MP of B. burgdorferi
were being transcribed under in vitro growth conditions, total RNA
was extracted as previously described [6]. Briefly, B. burgdorferi
cultures were propagated at pH 7.6/32uC to a density of 2–3610
7
spirochetes per ml. The samples were washed in HBSS and the
bacterial pellets resuspended in RNA-Bee (Tel-Test, Inc. Friends-
wood, TX) at a ratio of 0.2 ml for every 10
6 cells. Following
extraction with chloroform, the RNA was precipitated with
isopropanol, washed with 75% ethanol, air-dried, and resus-
pended in RNAse-free water. The RNA was treated twice at 37uC
for 45 minutes with DNaseI to remove any contaminating DNA
and total RNA quantified spectrophotometrically. In order to
evaluate sample RNA purity, real-time PCR was carried out using
recA primers (recAFq and recARq) to detect contaminating DNA
[6]. Samples devoid of contaminating DNA were reverse
transcribed to cDNA using TaqMan reverse transcription reagents
(Applied Biosystems, Foster City, CA) [10]. The cDNA was PCR
amplified using primers (Table 1) specific to the internal regions of
MP members bb0683-bb0688.
Cloning, Over-expression and Purification of
Recombinant Proteins
Total genomic DNA obtained from B. burgdorferi clonal isolate
MSK5 was used as template to PCR amplify pta (bb0589), ackA
(bb0622), hmgs (bb0683), hmgr (bb0685), mvaD (bb0686), pmk (bb0687),
or mvk (bb0688) using forward and reverse primers containing
appropriate engineered restriction enzyme sites (Table 1). The
amplicons were cloned into pCR2.1-TOPO vector (Invitrogen)
and transformed into E. coli TOP 10 cells and subjected to blue/
white colony screen in the presence of ampicillin (100 mg/ml) and
kanamycin (50 mg/ml). Respective inserts were excised with
appropriate restriction enzymes (Table 1) and ligated into either
the pMAL-p2X (New England Biolabs, Ipswich, MA) facilitating
Table 1. Oligonucleotides used in this study.
Name Sequence (59R39)
a
BB0589F/NdeI ACGCCATATGCAAAAGTTAAAGGGAGTTACGAAG
BB0589R/XhoI ACGCCTCGAGTTAAATGCTTATCATTAAAGCACTT
BB0622F/NdeI ACGCCATATGACAGAAAGATTTGAAAAAGG
BB0622R/XhoI ACGCCTCGAGTTTATTTAAAATTTCTGAGGATC
BB0683F/NdeI AGCGCATATGAGAATAGGTATTAGTGATATTAG
BB0683R/XhoI ACGCCTCGAGGGCTCGATACCCATAAACTCGG
BB0685F/BamHI ACGCGGATCCATGAACTTGGAGTCTTTAAGC
BB0685R/SalI ACGCGTCGACTTAAAGCTAAGGTTGCATGAACT
BB0686F/NdeI ACGCCATATGAAAATAAAGTGTAAAGTT
BB0686R/XhoI ACGCCTCGAGAATCCATTCTAAGTCACA
BB0687F/NdeI ACGCCATATGGATTTGATTAGTTTTTCT
BB0687R/XhoI ACGCCTCGAGGCATTTATCGCTTTC
BB0688F/NdeI ACGCCATATGCTAAGAATAAGAAAGCCT
BB0688R/XhoI ACGCCTCGAGAGTCTCAATTACCTT
BB0683cDNAF ACGCAACTTTCCAGGTTCAACATGCG
BB0683cDNAR ACGCTCCATAGCAGCTTCAACTCCATC
BB0684cDNAF ACGCATGACAGGGGGCAGTAAAGAGG
BB0684cDNAR ACGCCCAAGGCTGAACAATTCCTTAACG
BB0685cDNAF ACGCGAATCTTCTGTTGTTGCTGCCC
BB0685cDNAR ACGCGCTCGCTCCTCTTCGTAAAAACC
BB0686cDNAF ACGCTTCCCGACAGCAGCAGGCC
BB0686cDNAR ACGCTCCCCTCATTTAGCAAATCAGCAG
BB0687cDNAF ACGCGTTTGCTTACTTGAGTCAAAATTG
BB0687cDNAR ACGCTTTCATCTCCAAATTGCATTTC
BB0688cDNAF ACGCTTTCTGAAATTCCTATTGGAGTTG
BB0688cDNAR ACGCTCCTTATTCTGAAAAGAAGCATAAG
PflacF/BamHIKpnI ACGCGGATCCGGTACCGACGTCTAATACCGAGCTTCA
PflacR/EcoRV ACGCGATATCCATTGGAAACCTCCCTCAATTG
BB0685R/SalIKpnI ACGCCTCGAGGGTACCGTCGACTTAAAGCTAAGGTTG
aRestriction enzyme sites are underlined.
doi:10.1371/journal.pone.0038171.t001
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binding protein (MBP) or pET23a (Novagen) expression vector for
expression of recombinant proteins with a C-terminal 6X
Histidine tag (Table 2). Plasmid pET45b/Lmhmgr used for
purification of the listerial homolog of HMGR (LmHMGR) with
an N-terminal 6X Histidine tag was provided by JA Friesen [23].
Ligated products were electro-transformed into E. coli TOP 10
cells and screened by restriction enzyme digestion for the presence
of inserts of appropriate size. The junctions of plasmids containing
inserts of expected size were confirmed by sequence analysis and
these plasmids were used to electro-transform the E. coli expression
host (Rosettagami or M15). Transformants were plated on LB
agar containing ampicillin (100 mg/ml) and kanamycin (25 mg/ml)
(pMAL-p2X-hmgr) or LB agar containing ampicillin (100 mg/ml),
chloramphenicol (34 mg/ml), kanamycin (15 mg/ml), and tetracy-
cline (12.5 mg/ml) for the following constructs: pET23a/pta,
pET23a/ackA, pET23a/hmgs, pET23a/mvaD, pET23a/pmk,
pET23a/mvk, pET45b/Lmhmgr. Colonies were selected, grown
overnight at 37uC in 5 mL of LB containing antibiotics, and
transferred to one liter LB containing antibiotics and 0.2% glucose
and allowed to grow until reaching an optical density of 0.5 at
600 nm. Expression of recombinant proteins was induced by
addition of 1 mM isopropylthiogalactopyranoside (IPTG). For
expression of recombinant HMGR-MBP, the cells were allowed to
grow for 16 hrs at 16uC. Cells were harvested by centrifugation at
50006g for 10 min and resuspended in 20 ml low-salt buffer (LSB;
10 mM phosphate buffer, pH 7.0 containing 30 mM NaCl and
10 mM b-mercaptoethanol). Bacterial pellets were disrupted using
a French press and cell lysate was centrifuged at 85006g for
20 min. Supernatant was loaded onto an amylose column (New
England Biolabs) and the protein was purified using the Biologic
Duoflow Chromatography system (BioRad). The column was
washed with buffer A (LSB) and protein eluted with Buffer B (LSB
with 50 mM maltose). For expression of HMGS, MvaD, Pmk,
Mvk, Pta, AckA and LmHMGR, cells were allowed to grow for 4
hrs at 37uC, harvested by centrifugation at 5000 x g for 10 min
and resuspended in 5 ml lysis buffer. Bacterial pellets were
disrupted (French press) and the cell lysate centrifuged at 85006g
for 20 min. HMGS, MvaD, Pmk, Mvk, Pta and AckA were
purified to homogeneity using the S&S Elutrap electro-separation
method (Schleicher and Schull, Keene, NH) according to
manufacturer’s instructions. LmHMGR was subjected to affinity
purification using Ni-nitrilotriacetic acid (NiNTA) beads (QIAgen)
per manufacturer’s instructions. Bound histidine-tagged proteins
were eluted as 0.5 ml fractions with elution buffer (250 mM
imidazole). Purified proteins were analyzed by SDS-12.5%
polyacrylamide gel electrophoresis. Purified recombinant proteins
were quantified using the BCA protein assay (Pierce, Thermo
Fisher Scientific, Rockford, IL) and stored at 280uC until further
use.
Enzyme Assays
Recombinant B. burgdorferi HMGR enzyme activity was assayed
spectrophotometrically following the oxidation of NADPH to
NADP
+ at 340 nm. The reaction buffer consisted of 200 mM
KCl, 50 mM Tris-HCl, 1 mg/ml BSA, 0.17 mM HMG-CoA,
0.13 mM NADPH, and 0.5 mg enzyme at pH 7.5 in a final
reaction volume of 200 ml [23]. The reduction in absorbance at
340 nm was monitored at 5 sec intervals over a course of 30 sec
the resulting velocity was used to obtain a Lineweaver-Burk Plot
(not shown). Nonlinear regression using GraphPad Prism 4.0
software was used to calculate the Km and Vmax. Purified human
HMGR (Sigma-Aldrich, St. Louis, MO) and LmHMGR were
used as positive assay controls (data not shown). An additional
control included addition of purified maltose binding protein
(MBP) alone to the reaction buffer and enzyme assays performed
as described above. For inhibition assays, the reaction mixture was
supplemented with either lovastatin or simvastatin at a concen-
tration of 250 mM [23] or an equivalent volume of diluent
(DMSO) control and the enzyme assay was performed as
described above.
Generation of Anti-serum
Purified recombinant proteins (HMGR, MvaD, Pmk, Mvk, Pta
and AckA) were emulsified in equal volumes of Titermax
TM
(Sigma, St Louis MO) and used to immunize 6 to 8 week old
female BALB/c mice. Booster immunizations were given at days
14 and 21 [5–10]. Immunoblot analysis was carried out to
determine the specificity of the antibodies against the recombinant
proteins (data not shown) and total borrelial lysates with serum
obtained on day 28 post-immunization. All animal procedures
were conducted in accordance with an approved animal use
protocol from the Institutional Animal Care and Use Committee
of The University of Texas at San Antonio.
Sodium Dodecyl Sulfate-polyacrylamide Gel
Electrophoresis (SDS-PAGE) and Immunoblot Analysis
Whole-cell B. burgdorferi lysates were prepared and separated on
SDS-12.5% PAGE as previously described [5–10]. Separated
proteins were either visualized by Coomassie brilliant blue staining
or transferred onto a PVDF membrane (Amersham Hybond
TM-P;
GE Healthcare, Buckinghamshire, UK) and subjected to immu-
noblot analysis as previously described [5,7,8,10]. Membranes
were probed with a-OspA, a-HMGR, a-MvaD, a-Pmk, a-Mvk,
a-BBA34, a-BBK32, a-DbpA, a-OspC, a-Pta, a-P66, a-BBA64,
a-BosR, a-OppA1, a-OppA2, a-OppA3, a-OppA4, a-RpoS, a-
FlaB, a-NapA, and a-AckA antibodies. Blots were incubated with
appropriate concentrations of HRP conjugated anti-mouse, anti-
rat, or anti-rabbit secondary antibodies and developed using
ECL
TM Western blotting detection reagents (GE Healthcare).
Statin Activation
Simvastatin (Sigma-Aldrich, St. Louis, MO) was activated as
described by Robinzon, et al [52]. Briefly, 4 mg simvastatin was
resuspended in 150 ml 100% EtOH to which 150 ml 0.1 N NaOH
was added and the mixture incubated at 50uC for 2 hrs. The pH
was brought to 7.0 with HCl and the final volume was brought to
1 ml with ddH2O. Lovastatin (Sigma-Aldrich, St. Louis, MO) was
activated as described by Ghosh, et al [53]. Briefly, 5 mg lovastatin
was resuspended in 100 ml 100% EtOH to which 50 ml 0.6 M
NaOH was added, and the mixture was incubated at 50uC for
2 hrs. Following incubation, the pH was brought to 7.5 with 0.4 M
HCl and the final volume of the mixture was brought to 1 ml with
ddH2O. Statins in the inactivated form were resuspended in
DMSO to a final concentration of 20 mg/ml.
Effect of Statins on In vitro Growth of B. burgdorferi
Cultures of a clonal infectious isolate of B. burgdorferi strain
B31-A3 were grown to a density of 5610
7 cells per mL in BSK-
II media supplemented with 6% NRS at pH 7.6/32uC. Cells
were pelleted by centrifugation (40006g, 20 min at 4uC) and
washed three times with HBSS supplemented with 0.2% glucose.
After washing, cells were plated on 96-well plates containing
various dilutions (2.5–320 mg/ml) of statins, in both acid and
lactone forms [54]. The cells were treated with statins for 2 hrs
at 32uC. Following treatment, cells were washed three times with
HBSS +0.2% glucose. After washing, cells were resuspended in
Mevalonate Pathway of B. burgdorferi
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32uC in 96-well plates. Growth was scored at three weeks using
darkfield microscopy. All data are averages of three independent
assays. Data were subjected to unpaired Student’s t test
implemented in Excel software. Asterisks indicate values that
are statistically significantly different between control and treated
samples (***, P,0.001).
Effect of Statins on Viability of B. burgdorferi
B. burgdorferi strain B31-A3 was washed three times with HBSS
+0.2% glucose and treated with 2.5, 10, 20, 40 or 160 mg/ml of
statins for 2 hrs. After washing to remove free drug, the viability of
spirochetes was evaluated using the Live/Dead BacLight bacterial
viability kit (Molecular Probes, Invitrogen, Carlsbad, CA) in
conjunction with confocal microscopy [5,10]. Images were
captured using a Zeiss LSM510 microscope and deconvolved
using AutoQuantX (MediaCybernetics Inc., Bethesda, MD).
HMGR Overexpression Construct
Total genomic DNA obtained from B. burgdorferi clonal isolate
MSK5 (Table 1) was used as template to PCR amplify hmgr
(bb0685) while a plasmid designated pCR2.1/Pflac (unpublished
data, D. Scott Samuels) was used as template to PCR amplify Pflac
using forward and reverse primers in order to obtain appropriate
engineered restriction enzyme sites for subsequent cloning steps
(Table 1). The amplicons were cloned into pCR2.1-TOPO vector
(Invitrogen) and transformed into E. coli TOP 10 cells and
subjected to blue/white colony screen in the presence of ampicillin
(100 mg/ml) and kanamycin (50 mg/ml). Pflac was excised with
appropriate restriction enzymes (Table 1) and ligated into
pCR2.1/hmgr. The resulting Pflac/hmgr was excised with KpnI
and ligated into pBSV2/lacI [55,56], giving a plasmid designated
pTR1, in which the borrelial hmgr was placed under the control of
the IPTG-inducible Pflac promoter.
Generation of Borrelial HMGR Overexpression Strain
A clonal derivative of B. burgdorferi sensu stricto strain B31
lacking lp25, ML23, was electrotransformed with pTR1 using a
procedure described previously [57,58]. After electroporation, the
transformants were incubated for 48 h at 32uC in BSK-II growth
medium without antibiotics and plated on BSK-II agarose overlays
containing 200 mg/ml of kanamycin. The plates were incubated at
32uCi n1 %C O 2 for 21 days or until individual colonies were
visible in the overlays. Colonies were isolated aseptically into BSK-
II growth medium with 200 mg/ml of kanamycin until the density
reached 5610
7 spirochetes/ml. One ml of culture was used to
extract total genomic DNA and the presence of the plasmid was
confirmed using primers specific to the lacI gene. Three
transformants were identified as being positive for lacI, and one
of those clones, designated TR1 (Table 3) was used for further
study.
Induction of HMGR Expression in the Overexpression
Strain, TR1
TR1 was grown to a density of 5610
7 spirochetes/ml at which
time IPTG was added to a final concentration of 5 mM and
analyzed for expression of HMGR by immunoblot analysis. After
16 hrs of induction with IPTG, the cells were treated with statins
as described above.
Table 2. Plasmids used in this study.
Plasmid Description Source or reference
pCRH2.1-TOPO PCR cloning vector Invitrogen
pMAL-p2x Expression vector with an N-terminal maltose binding protein tag New England Biolabs
pET23a Expression vector with a C-terminal 6-His tag Novagen
pTV146 bb0685 cloned into pCR2.1 for protein expression This study
pTV147 bb0685 cloned into pMAL-p2x This study
pTV118 bb0686 cloned into pCR2.1 This study
pTV125 bb0686 cloned into pET23a This study
pTV119 bb0687 cloned into pCR2.1 This study
pTV101 bb0687 cloned into pET23a This study
pTV120 bb0688 cloned into pCR2.1 This study
pTV121 bb0688 cloned into pET23a This study
pTV131 bb0683 cloned into pET23a This study
pET45b/lmhmgr Lmhmgr cloned into pET45b [23]
pYL03 bb0589 cloned into pET23a This study
pYE04 bb0622 cloned into pET23a This study
pCR2.1/Pflac Pflac cloned into pCR2.1 Unpublished data, D. Scott Samuels
pTV142 Pflac cloned into pCR2.1 with KpnI and NheI restriction sites This study
pTV145 bb0685 cloned into pCR2.1 with NheI and EcoRV/KpnI restriction sites This study
pTV146 Pflac/bb0685 cloned into pCR2.1 with flanking KpnI sites This study
pBVS2/lacI Borrelial shuttle vector with kan
r and lacI under the control of PflgB [55,56]
pTR1 pBVS2/lacI with Pflac/bb0685 This study
doi:10.1371/journal.pone.0038171.t002
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Sequence Analysis of the Members of Mevalonate
Pathway (MP)
The contributions of CsrABb in regulating virulence gene
expression and adaptation of B. burgdorferi to vertebrate host have
been recently reported [6,10,37,38]. A key component of this
regulation is the intracellular levels of acetate. Acetate is
phosphorylated to acetyl-phosphate by the enzyme acetate kinase
(AckA; BB0622). The conversion of acetyl-phosphate to acetyl-
CoA by phosphate acetyltransferase (Pta, BB0589) appears to be a
critical switch in mediating the relay of signals for activation of the
linear gene regulatory network, Rrp2-RpoN-RpoS, resulting in
the expression of determinants facilitating the adaptation of B.
burgdorferi to vertebrate host. A previous report [39] and additional
bio-informatic analysis for potential pathways dependent on levels
of acetyl-CoA revealed that the borrelial genome contains several
ORFs with significant sequence similarity to members of the MP
in other organisms (Fig 2; Table 4). The initiating substrate of the
MP is acetyl-CoA, which is converted to acetoacetyl-CoA by
acetoacetyl transferase (ACAT; BB0109). Both acetyl-CoA and
acetoacetyl-CoA are used to generate HMG-CoA by the action of
HMG-CoA synthase (HMGS; BB0683). The conversion of HMG-
CoA to mevalonate by HMG-CoA reductase (HMGR; BB0685)
has been shown to be the rate-limiting step of the MP [59]. The
presence of ORFs with sequence similarity to mevalonate kinase
(Mvk; BB0688), phosphomevalonate kinase (Pmk; BB0687) and
mevalonate decarboxylase (MvaD; BB0686) to homologs present
in other bacteria and the conspicuous absence of members of the
non-mevalonate pathway suggest that isopentenyl pyrophosphate,
a central metabolic intermediate for cell wall biogenesis and post-
translational modification of proteins, is generated in B. burgdorferi
via the MP.
bb0685 Encodes a Class II HMGR
Genomes of organisms classified under each of the three
domains of life are known to carry homologs of HMGR [60].
While Class I homologs of HMGR characterized by the presence
of an N-terminal membrane-anchoring domain are found in
eukaryotes and some archaea, the Class II homologs lacking this
N-terminal domain are present in some eubacteria and archaea
[21]. Both classes have a catalytic domain for the binding of
HMG-CoA [61]. Sequence alignment of three eubacterial (Class
II; Listeria monocytogenes, Pseudomonas mevalonii, and Staphylococcus
aureus) and four eukaryotic (Class I; Homo sapiens, Mesocricetus
auratus, Drosophila melanogaster, and Saccharomyces cerevisiae) HMGR
sequences with that of B. burgdorferi (BB0685) revealed high degree
of similarity in the binding sites for HMG-CoA and NAD(P)H
(Fig. 2), indicating that borrelial HMGR has the ability to catalyze
the conversion of HMG-CoA to mevalonate and this pathway
could link the levels of acetate to the end-products of MP. The
borrelial homolog has ENYIG as the residues at the potential
HMG-CoA binding site (sequence underscored by squares, Fig. 2)
while other homologs have residues EN(T/V)(I/L)G. The first
region for NAD(P)H binding (sequence underscored by triangles,
Fig. 2), is conserved among all eight species (DAMGAN for Class
II and DAMGMN for Class I) while there was variation in the
second binding region. Three or four of the five residues of the B.
burgdorferi HMGR binding site are conserved when compared to
the HMGRs of other species. The borrelial homolog also has
conserved residues (indicated by asterisks, Fig. 2) that have been
implicated in catalysis in Pseudomonas mevalonii HMGR [29], the
canonical Class II HMGR. These observations, in conjunction
with enzyme kinetics described below indicate that bb0685 in B.
burgdorferi encodes a Class II HMGR.
HMGR from B. burgdorferi Exhibits Enzyme Activity
As shown in Fig 3A, the borrelial homolog of HMGR was
purified as an MBP-fusion protein and was used to for enzyme
kinetic analysis. Purified B. burgdorferi HMGR was tested for its
ability to convert HMG-CoA into mevalonate. The reaction was
monitored spectrophotometrically at 340 nm following decreasing
absorbance as NADPH was oxidized NADP
+. The calculated Km
for B. burgdorferi HMGR is 132 mM. When compared to other
Class II HMGR Km values, the B. burgdorferi HMGR has a Km value
between 3- and 8-fold higher (Table 5). The calculated Vmax of B.
burgdorferi HMGR is 1.92 mmol NADPH oxidized minute
21 (mg
protein)
21. Consistent with lower substrate affinity, the calculated
Vmax of B. burgdorferi is lower than that of other HMG-CoA
reductases.
Statins Inhibit B. burgdorferi HMGR
We further examined if the HMGR activity of the borrelial
homolog can be inhibited with specific, clinically used, HMG-CoA
reductase inhibitors, i.e., statins. As shown in Fig 3B, both
lovastatin and simvastatin were inhibitory to B. burgdorferi HMGR
at a concentration of 250 mM [22]. The velocity of the control
reaction was calculated as 1.4160.10 mmol NADPH oxidized
minute
21 (mg protein)
21
. Lovastatin reduced HMGR activity to
61.4% of maximal activity (velocity of 0.6860.07 mmol NADPH
oxidized minute
21 (mg protein)
21), while simvastatin lowered
HMGR activity to 48.2% of maximal (velocity of 0.8760.08 mmol
NADPH oxidized minute
21 (mg protein)
21). These observations
suggest that if the B. burgdorferi HMGR homolog plays a central
role in the MP, B. burgdorferi HMGR could be a useful target
enzyme for inhibitory agents such as statins.
Transcriptional Analysis of ORFs of the MP in
B. burgdorferi
In order to validate the in silico prediction of the presence of
ORFs and determine the significance of the contributions of the
members of the MP in the patho-physiology of B. burgdorferi,w e
carried out RT-PCR using primers specific to internal regions of
Table 3. Borrelia burgdorferi strains used in this study.
B. burgdorferi strain Description Source or reference
A3 B31 isolate with all infection-associated plasmids capable of transformation [50,71]
MSK5 B31 isolate with all infection-associated plasmids [49]
ML23 B31 isolate lacking lp-25; non-infectious [49]
TR1 ML23 transformed with pTR1 This study
doi:10.1371/journal.pone.0038171.t003
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when the primers specific to bb0683, bb0684, bb0685, bb0686,
bb0687 and bb0688 were used with cDNA generated from total
RNA extracted from MSK5, there was amplification of an
approximate 400 bp fragment consistent with the amplicons size
observed with MSK5 genomic DNA amplification (Fig. 4B; 4C,
Lane 4). No amplification was observed when double distilled
water (ddH2O) or total RNA (-RT) were used as PCR templates in
the PCR mix (Fig. 4B, 4C, Lanes 1 and 2 respectively). We then
determined if the genes of the mevalonate pathway were co-
transcribed (Fig. 4D and 4E). No amplification was observed when
primer sets corresponding to adjacent ORFs were used with
cDNA generated from total MSK5 RNA (Fig. 4D, 4E, Lane 3)
while amplification of appropriate product was observed when
total MSK5 genomic DNA was used as template (Fig. 4D, 4E,
Lane 4). As expected, no amplification occurred when ddH2Oo r
total RNA (–RT) were used as controls (Fig. 4D, 4E, Lanes 1 and
2, respectively). Taken together, these observations indicate that
genes of the mevalonate pathway are transcribed under in vitro
growth conditions employed. However, the MP genes are not
being co-transcribed as members of an operon (Fig. 4D, 4E).
Levels of Expression of Members of the MP in
B. burgdorferi
In order to determine if the transcriptional levels of members
of the MP are reflected at the translational level, we determined
the protein levels of a few members of the MP using mono-
specific serum generated using recombinant proteins. There was
increased expression of HMGR in an infectious clonal isolate of
B. burgdorferi (B31-A3) that was propagated under conditions that
mimicked fed ticks (pH 6.8/37uC; Fig. 5B, Lane 2, a-HMGR)
when compared to that of unfed conditions (pH 7.6/23uC;
Fig 5B, Lane 1, a-HMGR). However, the levels of Mvk, Pmk,
and MvaD were elevated to varying degrees under conditions
that mimicked unfed ticks (Fig 5B, Lane 1, a-Mvk, a-Pmk a-
MvaD). The levels of these enzymes are therefore partly
dependent on the host specific external signals such as
Figure 2. Sequence comparison of HMGR homologs. ClustalX alignment of HMGR from eight different species, representing both Class II
(Borrelia burgdorferi, Listeria monocytogenes, Pseudomonas aeruginosa, Staphylococcus aureus) and Class I (Human, Syrian Hamster, Drosophila
melanogaster, and Saccharomyces cerevisiae) shows a high degree of similarity with regard to binding sites for HMG-CoA/HMG-CoA reductase
inhibitors (ENVIG - boxes) and NAD(P)H (DAMGXN and GTVGG - triangles). Indicated by stars are conserved residues shown to be important for
catalysis of HMGR in Pseudomonas mevalonii [29].
doi:10.1371/journal.pone.0038171.g002
Table 4. Sequence comparison of B. burgdorferi mevalonate pathway proteins to characterized homologs in other bacterial
species.
Species [ref]
B. burgdorferi
[this study] L. monocytogenes [23] S. aureus [26] P. mevalonii [22] H. volcanii [72]
Syrian
Hamster [73] Human [74]
Km 132622 19.861.2 40 20 60 20 4.460.7
Vmax 1.9260.16 18.260.5 21 66 34 64 188635
doi:10.1371/journal.pone.0038171.t004
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adaptation to either the tick vector or the vertebrate host [62–
66]. These observations suggest that the level of the rate-limiting
enzyme HMGR is up-regulated under environmental conditions
that mimic the vertebrate host and hence could be a rational
target for inhibition to alter the adaptation of B. burgdorferi.
Effect of Acetate on Protein Expression Profiles in
B. burgdorferi
In addition to pH and temperature, we observed that increased
levels of extracellular acetate could modulate vertebrate host-
specific adaptation [9]. Since acetyl-CoA is the initial substrate of
the MP, we hypothesized that the levels of acetyl-CoA could alter
levels of the members of the MP in B. burgdorferi. We therefore
determined levels of a variety of determinants that were altered in
response to borrelial culture conditions with increased supple-
mentation of acetate. Whole cell lysates from B. burgdorferi (A3)
were propagated under fed-tick (pH 6.8/37uC), laboratory
(pH 7.6/32uC), and unfed-tick (pH 7.6/32uC) growth conditions
(Figs. 6, 7, and 8, respectively) with increasing levels of
supplemental acetate (0, 15, 30, and 90 mM), separated by
SDS-12.5% PAGE electrophoresis and stained with Coomassie
Brilliant Blue (Figs. 6A, 7A, and 8A) or transferred to PVDF
membranes for immunoblot analysis (Figs. 6B-F, 7B-F, and 8B-F).
Figure 3. Statins inhibit the enzyme activity of B. burgdorferi HMGR. (A) Lysates purified HMGR as indicated above the respective lanes were
resolved by SDS-12.5%PAGE. Gels were stained with Coomassie blue. Recombinant HMGR of B. burgdorferi purified by FPLC. Lane 1, non-induced E.
coli containing pMAL-p2X/hmgr. Lane 2, E. coli containing pMAL-p2X/hmgr induced with 1 mM IPTG. Lane 3, Purified MBP-HMGR fusion protein. (B)
Recombinant B. burgdorferi HMGR activity was measures as described under Materials and Methods. Statins were added to the enzyme reaction at a
concentration of 250 mM. The velocity of the control reaction was calculated as 1.4160.10 mmol NADPH oxidized minute
21 (mg protein)
21, set as
100% maximal activity in the presence of the statin diluent, DMSO, alone. Simvastatin lowered HMGR activity to 48.2% of maximal (velocity of
0.8760.08 mmol NADPH oxidized minute
21 (mg protein)
21), while lovastatin reduced HMGR activity to 61.4% of maximal activity (velocity of
0.6860.07 mmol NADPH oxidized minute
21 (mg protein)
21). Data shown are the average of three independent assays. Asterisks indicate samples
whose values are statistically significantly different between control and treated conditions (**, P,0.01).
doi:10.1371/journal.pone.0038171.g003
Table 5. Kinetic values for HMG-CoA reductases of different species
a.
B. burgdorferi Protein Enzyme name
% Identity
(L. monocytogenes/S. aureus) % Similarity (L. monocytogenes/S. aureus)
AckA/BB0622 Acetate kinase 44/43 66/65
Pta/BB0589 Phosphate acetyltransferase 44/45 65/67
ACAT/BB0109 Acetyl-CoA acetyltransferase 36/35 57/55
HMGS/BB0683 HMG-CoA synthase 29/29 49/48
HMGR/BB0685 HMG-CoA reductase 34/34 53/54
Mvk/BB0688 Mevalonate kinase 28/28 47/48
Pmk/BB0687 Phosphomevalonate kinase 22/21 39/42
MvaD/BB0686 Phosphomevalonate decarboxylase 34/31 54/51
Fni/BB0684 Isopentenyl-diphosphate isomerase 30/28 50/53
aKm and Vmax for B. burgdorferi were derived from the experiments described in Materials and Methods and are the average of three independent replicates. Km is in
units of mMa n dVmax is in units of mmol NADPH oxidized minute
21 (mg protein)
21
. L. monocytogenes (Listeria monocytogenes), S. aureus (Staphylococcus aureus),
P. mevalonii (Pseudomonas mevalonii), H. volcanii (Haloferax volcanii).
doi:10.1371/journal.pone.0038171.t005
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the level of OspC with increasing acetate, indicating increased
levels of acetate were sufficient to increase the levels of OspC, even
under temperature and pH conditions normally associated with
unfed ticks (pH 7.6/23uC; Fig 7A). An increase in levels of
HMGR, Mvk, Pmk and MvaD in B. burgdorferi propagated in
media with increased levels of acetate (90 mM) was observed
under fed (pH 6.8/37uC, Fig 6B), unfed (pH 7.6/23uC, Fig 8B) or
laboratory growth conditions (pH 7.6/32uC, Fig 7B). Previously
we noted that there were increased levels of OppA5 under pH/
temperature mimicking fed-tick conditions (with no supplemental
acetate) and were able to also show this increase in OppA5 with
supplemental acetate independent of the temperature and pH
(Figs 6B, 7B and 8B; a-OppA5). The levels of OppA1, OppA2,
and OppA4 appeared to be constitutive and did not change
following variation in the level of acetate or other environmental
conditions such as temperature and pH (Figs. 6B and 8B; a-
OppA1, a-OppA2, a-OppA4), with the exception of an increase
seen in the levels of OppA2 under laboratory growth conditions
(Fig. 7B; a-OppA2).
In order to further validate the effects of added acetate on the
adaptation of B. burgdorferi to host-specific conditions, we
determined levels of key regulators of gene expression as well as
the select determinants increased in response to alterations in
levels of borrelial regulators. Both RpoS and CsrABb were
increased in response to increasing levels of acetate under fed-
tick, laboratory, or unfed-tick specific growth conditions (Figs. 6D,
7D, 8D; a-RpoS, a-CsrABb). While the level of BosR under
laboratory growth conditions was increased in response to
supplemental acetate (Fig 7D; a-BosR), no change in the level of
BosR was observed under fed- or unfed tick conditions, (Fig. 6D,
8D; a-BosR). Additionally, the level of acetate kinase (AckA), the
first key enzyme that modifies acetate to acetyl-phosphate, was
elevated with increasing levels of supplemental acetate (Figs. 6E,
7E, 8E; a-AckA). Consistent with previous reports that CsrABb acts
to repress phosphate acetyl transferase (pta), we observed that levels
of Pta were lower with increasing levels of acetate and coincided
with increased levels of CsrABb. Many lipoproteins critical for
infection of the mammalian host, i.e., DbpA, BBK32, and OspC
were elevated with the increased RpoS and CsrABb with increased
added acetate under temperature and pH conditions mimicking
Figure 4. ORFs encoding members of the MP are transcribed in B. burgdorferi. (A) Schematic representation of the borrelial mevalonate
pathway that extends from bb0683 to bb0688. The arrows with numbers refer to primers used for the RT-PCR amplicons (depicted in B-E) separated
on a 1% agarose gel stained with ethidium bromide. (B-E) The templates used in PCR amplification (B-E) are from B. burgdorferi strain B31 clonal
isolate MSK5 and are as follows: Lane 1, PCR master mix with no template (double-distilled H2O control); Lane 2, total RNA (-RT control); Lane 3, cDNA
(+RT); Lane 4, total genomic DNA. Lanes M and M2, molecular size markers in kilobases (M) or base pairs (M2) as indicated on the left and right sides,
respectively. (B) Primers specific for bb0683 (1 and 2) and bb0684 (3 and 4) amplified cDNA (lane 3) and genomic DNA (lane 4). (C) Primers specific for
bb0685 (5 and 6), bb0686 (7 and 8), bb0687 (9 and 10) and bb0688 (11 and 12) amplified cDNA (lane 3), and genomic DNA (lane 4) indicating active
transcription of these ORFs. (D) Primers specific for the overlapping regions bb0683-bb0684 (1 and 4), bb0684-bb0685 (3 and 6) amplified genomic
DNA (lane 4), but not cDNA (lane 3) indicating that the ORFs are not co-transcribed. (E) Primers specific for the overlapping regions bb0685-bb0686 (5
and 8), bb0686-bb0687 (7 and 10) and bb0687-bb0688 (9 and 12) amplified genomic DNA (lane 4) but not cDNA (lane 3), indicating that the ORFs are
not co-transcribed The images were generated using the Versadoc imaging system (Bio-Rad Laboratories, Hercules, CA).
doi:10.1371/journal.pone.0038171.g004
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BBK32, a-OspC). The only lipoprotein that did not show a
significant difference was OspA (Figs. 6F, 7F, 8F; a-OspA). In
addition to OspA, the levels of several other determinants such as
1) P66, an outer membrane protein that functions as a porin, 2) the
major flagellin FlaB, and 3) a protein implicated in oxidative stress
response, NapA, remained unchanged with increasing concentra-
tions of acetate under different host-specific growth conditions
tested (Figs. 6G, 7G, 8G; a-P66 a-FlaB and a-NapA). In summary,
increasing acetate concentrations indicated that the MP in B.
burgdorferi is responsive to levels of the initiating substrate acetyl-
CoA. Moreover, the levels of regulators and lipoproteins indicative
of adaptation of B. burgdorferi to conditions that mimic the fed tick
or vertebrate host were all elevated in response to increasing levels
of acetate and this effect was similar under different host-specific
temperature or pH.
Effect of Statins on Growth of B. burgdorferi
Based on the ability of select statins to inhibit recombinant
borrelial HMGR, we evaluated the sensitivity of an infectious
clonal isolate of B. burgdorferi strain B31-A3 with lovastatin and
simvastatin either in the lactone (inactive) or acid (active) form
prepared as described under Materials and Methods. As shown in
Fig 9, DMSO (diluent) treated spirochetes were mostly alive with
89.6% viability (Fig 9A-B; green) under these experimental
conditions while cells treated with 10 mg/ml of simvastatin or
lovastatin showed significantly decreased viability (34.5% and
53.3%, respectively) and a mixture of live and dead (green/red;
Fig. 9C-D) when analyzed by confocal microscopy. Treated
spirochetes were resuspended in BSK-II media and grown for
three weeks at 32uC. Growth was observed after three weeks using
dark field microscopy and by change in the color of culture wells.
The lactone form of simvastatin had a bactericidal concentration
of 20 mg/ml while the lactone form of lovastatin had a bactericidal
concentration of 45 mg/ml. The bactericidal concentration of the
acid forms of simvastatin and lovastatin were 52.5 and 100 mg/ml,
respectively. Simvastatin was a more potent inhibitor of borrelial
growth under the specific conditions tested (Fig. 9D) compared to
lovastatin. Both forms of the drugs inhibited spirochetal growth
significantly (P,0.001) compared to that of spirochetes treated
with the diluent or vehicle alone.
To indicate the importance of HMGR as the target of statins,
we used the HMGR overexpression strain of B. burgdorferi, TR1, to
determine whether the increased presence of HMGR would
confer an increased resistance to statin treatment. As shown in
Figure 10, TR1 has a significantly increased resistance to
simvastatin and lovastatin (P,0.01) when compared to resistance
of the parent strain, ML23.
Taken together, these observations demonstrate that statins can
inhibit the activity of B. burgdorferi HMGR and subsequent growth
of the bacteria, and the growth inhibition can be partially
overcome with the overexpression of HMGR in B. burgdorferi. Thus
it is important to characterize further the inhibitory effects of
statins such that their use can possibly be extended to reduce the
transmission of these spirochetes between reservoir hosts, ticks and
dead-end vertebrate hosts.
Discussion
The genome of B. burgdorferi encodes for limited metabolic
capabilities which brings into focus the relevance of pathways that
are apparently intact [16]. One such pathway is the mevalonate
pathway (MP) that contains ORFs with significant identity to
homologs in other bacterial systems indicating the importance of
isopentenyl-5-pyrophosphate (IPP) - a key metabolic intermediate
of this pathway. Since several metabolic processes, notably
peptidoglycan biosynthesis and cell wall formation are dependent
on the synthesis of IPP, pathways that lead to the synthesis of IPP
are found across all three domains of life [27,28]. Most organisms,
including B. burgdorferi, possess the MP for IPP biosynthesis while
others synthesize IPP through the more recently identified MEP/
DOXP pathway [16]. We focused on the biochemical character-
ization of the MP, as it would expand our understanding of the
nature of interactions between B. burgdorferi and its vertebrate or
tick host. Moreover, the availability of a wide variety of statins
exhibiting different pharmacokinetic properties to inhibit the rate-
limiting enzyme (HMGR) of the MP in B. burgdorferi opens an
avenue to evaluate an array of compounds potentially capable of
preventing the transmission, colonization, and/or dissemination of
the bacteria to vertebrate hosts [30,31,35].
Figure 5. Levels of proteins of the MP in B. burgdorferi. Equivalent
number of spirochetes from B. burgdorferi strain B31-A3 propagated in
BSK-II medium with 6% NRS under conditions that either mimicked the
unfed-tick (pH 7.6/23uC; Lane 1) or fed-tick (pH 6.8/37uC; Lane 2) to a
density of 5 6 10
7 spirochetes/ml were resolved by SDS-12.5%PAGE.
Gels were stained with Coomassie blue (A) or separated proteins were
electrotransfered onto PVDF membranes. (B) Immunoblots were
incubated with mouse serum against purified HMGR, MvaD, Pmk,
Mvk and P66 respectively. Blots were developed using the Enhanced
Chemiluminescence system. Numbers to the left of the panels indicate
the molecular mass standards in kilodaltons proximate to each of the
antigens. Higher levels of HMGR expression were seen under fed-tick
conditions when compared to unfed-tick conditions while the other
three proteins showed higher levels of expression under unfed-tick
conditions when compared to fed-tick conditions.
doi:10.1371/journal.pone.0038171.g005
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MP is dependent on levels of acetyl-CoA in B. burgdorferi (Fig 1).
Recent reports have described the contribution of intra-cellular
acetate in the form of acetyl-phosphate in providing the
activation signal to phosphorylate the response regulator Rrp2
which in turn leads to activation of the RpoN-RpoS regulatory
pathway that facilitates adaptation by B. burgdorferi to vertebrate
host-specific conditions [9,37,39]. An important determinant of
this linear activation pathway is the balance in the levels of
intracellular acetate, acetyl-phosphate and acetyl-CoA. Intracel-
lular acetate is converted to acetyl-phosphate by the action of the
enzyme acetate kinase (AckA) and in turn serves as a substrate
for the enzyme phosphate acetyltransferase (Pta) which gives rise
to acetyl-CoA. We and others have recently shown that increased
levels of acetate transport and repression of Pta by the small
RNA binding protein CsrABb leads to increased levels of acetyl-
phosphate which in turn leads to activation of the Rrp2-RpoN-
RpoS pathway [9,36,39]. In this study, we determined the effect
of intracellular acetate in not only activating the Rrp2-RpoN-
RpoS pathway but also in its role for providing the initial
substrate (acetyl-CoA) of the MP in B. burgdorferi. Moreover, we
also determined the modulation of the levels of key enzymes
(AckA and Pta) that are responsible for generating substrates that
link intracellular acetate levels in activating gene regulatory
networks as well as other metabolic pathways (such as the MP)
that are operative in B. burgdorferi [67,68]. Hence, the biochem-
ical analysis of the MP links host-specific adaptation with vital
Figure 6. Effect of increasing concentrations of sodium acetate on levels of borrelial proteins under conditions that mimic fed-ticks.
Equivalent numbers of spirochetes from B. burgdorferi B31-A3 propagated in BSK-II medium with 6% NRS under conditions that mimicked the fed-tick
(pH 6.8/37uC) with increasing concentrations of supplemental NaOAc (from 0 mM - 90 mM) were resolved by SDS-12.5%PAGE. The gels were stained
with Coomassie blue (A) or the separated proteins were electrotransfered onto PVDF membranes. Immunoblots (B-G) were probed with anti-serum
against the antigens listed to the right of the blots. Blots were developed using the Enhanced Chemiluminescence system. The numbers to the left of
the panels indicate the molecular mass standards in kilodaltons proximate to each of the antigens. Increased levels were seen with increasing
concentrations of NaOAc for all proteins of the mevalonate pathway (B); OppA5 (C); gene regulators RpoS and CsrABb (D); AckA (E); pathogenesis-
related proteins DbpA, BBK32, and OspC (F). Decreased levels of protein expression were seen with OppA2 (C), Pta (E), and FlaB (G). Acetate levels had
no effect on the other proteins tested.
doi:10.1371/journal.pone.0038171.g006
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translational modifications in B. burgdorferi.
The ability of simvastatin and lovastatin to inhibit the HMGR
activity indicated that the borrelial homolog is a bona fide HMG-
CoA reductase, whose activity can be inhibited with micromolar
concentrations of statins (Fig 3B). The effects of statins were also
evident in the growth inhibition observed with B. burgdorferi treated
with simvastatin or lovastatin (Fig. 9A-G). The inhibitory property
of stains has several implications for interactions of B. burgdorferi
with its hosts. For example, statins can directly inhibit the MP of B.
burgdorferi and alter the cell wall biosynthesis or modulate the
incorporation of cholesterol derivatives into glycolipids in verte-
brate hosts that play a role in the transmission kinetics of the
spirochetes and thereby have the potential to alter the incidence of
Lyme disease. Moreover, the availability of a wide range of statins
with different pharmacokinetics properties provide an attractive
platform to develop formulations that can target the reservoir hosts
to reduce their spirochetal burden and provide strategies to reduce
the transmission of this tick-borne pathogen.
The adaptation of B. burgdorferi to highly disparate environmen-
tal signals present in the tick vector or vertebrate host has been
extensively studied and a variety of signals such as temperature,
pH, levels of dissolved gases, and other undefined host factors are
known to rapidly alter gene expression to facilitate adaptation to
the respective hosts [11,40–45,69]. In line with these observations,
it was important to determine if the members of the MP are
Figure 7. Effect of increasing concentrations of sodium acetate on levels of borrelial proteins under laboratory growth conditions.
Equivalent numbers of spirochetes from B. burgdorferi B31-A3 propagated in BSK-II medium with 6% NRS at laboratory growth conditions (pH 7.6/
32uC) with increasing concentrations of supplemental NaOAc (from 0 mM –90 mM) were resolved by SDS-12.5%PAGE. The gels were stained with
Coomassie blue (A) or the separated proteins were electrotransfered onto PVDF membranes. Immunoblots (B-G) were probed with anti-serum
against the antigens listed to the right of the blots. Blots were developed using the Enhanced Chemiluminescence system. Numbers to the left of the
panels indicate the molecular mass standards in kilodaltons proximate to each of the antigens. Increased levels of protein expression were seen with
increasing concentrations of NaOAc for all proteins of the mevalonate pathway (B); OppA5 (C); gene regulators RpoS, CsrABb, and BosR (D); AckA (E);
pathogenesis-related proteins DbpA, BBK32, and OspC (F); NapA (G). Decreased levels of protein expression were seen with Pta (E). Acetate levels had
no effect on the other proteins tested.
doi:10.1371/journal.pone.0038171.g007
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gut before and after a blood meal. As shown in Fig 5, the levels of
HMGR were up-regulated under fed-tick conditions (Fig. 5B, 5C,
Lane 2) compared to unfed-tick conditions (Fig 5B, 5C Lane 1)
while the other three downstream enzymes of the MP were up-
regulated under the tick-specific conditions B. burgdorferi.I ti s
possible that under fed-tick conditions, where the levels of acetyl-
CoA are low due to repression of pta by CsrABb (data not shown),
an increase in the levels of HMGR, the rate limiting enzyme of
MP, may be needed to generate sufficient levels of mevalonate
while the levels of other enzymes under these conditions could be
sufficient to obtain the end product, namely IPP. Since IPP is
essential for peptidoglycan biosynthesis and the bacteria undergo
more rapid growth following the ingestion of a blood meal by the
ticks, it is logical that the rate-limiting enzyme in the IPP
biosynthetic pathway would be upregulated under these specific
conditions. It is also possible that the regulation of the members of
the MP is different in response to alterations in pH and
temperature, accounting for the differences in the levels of HMGR
compared to other members of the MP. Nonetheless, the host-
specific conditions do appear to alter the levels of the enzymes of
the MP and probably coincide with the need for synchrony in
regulating metabolic pathways consistent with host-specific adap-
tation.
Since acetyl-CoA is the initiating substrate, we further examined
the effect of levels of acetate both on synthesis of the members of
the MP as well as on regulators and determinants that are
synthesized differentially under vertebrate host-specific conditions.
Recent studies have shown that the increased transport of acetate
into the bacterium allows for an increased upregulation of
Figure 8. Effect of increasing concentrations of sodium acetate on levels of borrelial proteins under conditions that mimic unfed
ticks. Equivalent numbers of spirochetes from A3 propagated in BSK-II medium with 6% NRS under conditions that mimicked the unfed-tick (pH 7.6/
23uC) with increasing concentrations of supplemental NaOAc (from 0 mM –90 mM) were resolved by SDS-12.5%PAGE. The gels were stained with
Coomassie blue (A) or the separated proteins were electrotransfered onto PVDF membranes. Immunoblots (B-G) were probed with anti-serum
against the antigens listed to the right of the blots. Blots were developed using the Enhanced Chemiluminescence system. Numbers to the left of the
panels indicate the molecular mass standards in kilodaltons proximate to each of the antigens. Increased levels of protein expression were seen with
increasing concentrations of NaOAc for all proteins of the mevalonate pathway (B); OppA4, OppA5 (C), gene regulators RpoS and CsrABb (D); AckA (E);
pathogenesis-related proteins DbpA, BBK32, and OspC (F). Decreased levels of protein expression were seen with Pta (E). Acetate levels had no effect
on the other proteins tested.
doi:10.1371/journal.pone.0038171.g008
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normally funneled to produce acetyl-CoA, one of the starting
components of the mevalonate pathway, it follows that increased
acetate availability would lead to increased acetyl-CoA produc-
tion, facilitating increased expression of proteins involved in MP.
Consistent with this hypothesis, the levels of all the members of
MP tested were increased in spirochetes propagated in media with
90 mM of supplemental acetate. This was true under conditions
that mimicked the fed tick (Fig. 6B; pH 6.7/37uC), unfed tick
(Fig. 8B; pH 7.6/23uC) or under laboratory growth conditions
(Fig. 7B; pH 7.6/32uC).
Consistent with our previous report [9], the level of OppA5 was
elevated in response to increasing levels of supplemental acetate.
Interestingly, the increased levels of supplemental acetate (90 mM
acetate) were capable of increasing the levels of RpoS and CsrABb,
and therefore members of the rpoS regulon such as DbpA, BBK32
and OspC were elevated as well. It is not clear whether higher
levels of regulators of vertebrate host-specific gene expression such
as RpoS and CsrABb or the higher levels of acetate alone are
Figure 9. Sensitivity of B. burgdorferi to statins in the lactone or acid form. The spirochetes were treated with statins as described under
Materials and Methods and analyzed for sensitivity by different methods. (A) Percent viability of B. burgdorferi treated with 10 mg/ml of simvastatin
and lovastatin as determined by live/dead staining in conjunction with confocal microscopy. The percent viability is significantly reduced in statin
treated bacteria when compared to cells treated with an equivalent volume of DMSO. (B-D) Confocal microscopy of live/dead stained B. burgdorferi
following treatment with statins for two hours. Cells treated with DMSO (B) are green indicating live cells while those treated with 10 mg/ml of
simvastatin (C) or lovastatin (D) are a mixture of green and red, indicating cell death. (E) Data shown are the average of three independent assays;
bars indicate the standard deviation. Between 20 and 100 mg/ml simvastatin and lovastatin in either the acid (grey bars) or lactone (black bars) form
inhibit growth of B. burgdorferi in vitro while the DMSO control appears to have no detrimental effect.
doi:10.1371/journal.pone.0038171.g009
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contribute to the transport of acetate from the extracellular milieu
and serve as a mediator connecting the external signals to adaptive
gene expression in B. burgdorferi.
We and others have observed reduction in the levels of FlaB
when csrABb was over-expressed in trans from a plasmid expressing
csrABb under the control of constitutive borrelial promoter PflgB or
using an IPTG inducible plasmid [10,38,70]. Since csrABb (bb0184)
is the terminal ORF of a large flgK motility operon, it appears that
the effect of increased levels of CsrABb not synchronized with levels
of other motility related genes may contribute directly or indirectly
to the reduction in levels of FlaB. In this study, the increased levels
of csrABb expressed from the native copy on the chromosome in
response to increased levels of acetate do not appear to repress flaB
or alter its synthesis presumably due to synchronized levels of other
members of the flgK motility operon. We are also aware of the
effect of levels of CsrABb on other members of the flgK motility
operon, which in turn, could affect the levels of FlaB directly or
indirectly (Karna and Seshu, unpublished data).
A critical link to the levels of acetate and the regulators of
vertebrate host-specific gene expression appears to be the level of
acetyl-phosphate, as we observed increased levels of the enzyme
acetate kinase (AckA) while there was a reduction in the levels of
phosphate acetyltransferase (Pta), which is involved in converting
acetyl-phosphate to acetyl-CoA (Fig. 1). It is important to note that
increased acetate was able to modulate vertebrate host-specific
adaptation even under environmental signals that are reflective of
conditions present in the mid-gut of unfed ticks (pH 7.6/23uC;
Fig. 8D-F), suggesting that minor modifications in the external
signals could alter the response in B. burgdorferi. It can be argued
that the levels of acetate used in this study are not physiological
and that levels of these proteins may be partially reflective of what
is observed under vertebrate host-specific conditions [9,39]. It
should be pointed out that the serum level of acetate in rodents is
higher than the level of acetate in borrelial growth medium [39]
and that this signaling mechanism does not incorporate other host-
derived factors that could exert synergistic effects in addition to
acetate in modulating the levels of these determinants.
In summary, we have shown that acetate serves as a key
substrate that can modulate gene regulatory networks critical for
vertebrate host-specific gene expression in B. burgdorferi and plays a
central role in connecting metabolic pathways critical for growth
and survival of B. burgdorferi with host-specific adaptation (Fig. 1).
These studies have also added the contributions of extracellular
factors such as acetate that may vary in concentration in different
hosts as critical signals altering regulation of gene expression in B.
burgdorferi. In conclusion, B. burgdorferi has a functional MP and
acetate plays a critical role in modulating the vertebrate host-
specific adaptation in conjunction with pathways that are essential
for survival and growth of B. burgdorferi. These studies also helped
identify pathways and proteins that could be targeted for
inhibition in reservoir hosts, thereby expanding our ability to
reduce the incidence of Lyme disease.
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